Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The journey from chemical synthesis to life-saving medication is often complex, with each intermediate playing a vital role. In the realm of oncology, Lenvatinib Mesylate has emerged as a significant therapeutic agent, and its efficient synthesis hinges on the availability of high-quality Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4). This compound, a specialized quinoline derivative, forms a critical part of the molecular architecture of Lenvatinib, a powerful multi-receptor tyrosine kinase inhibitor.
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the pharmaceutical industry by providing superior quality pharmaceutical intermediates. As a prominent lenvatinib intermediate supplier in China, we specialize in the production and distribution of Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate, ensuring it meets the stringent purity requirements (typically >98.0% HPLC) necessary for API synthesis. Our commitment to excellence makes us a reliable partner for manufacturers worldwide.
The precise chemical structure of Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate is designed to undergo specific reactions that ultimately build the Lenvatinib molecule. Its role as a key intermediate means that any variability in its quality can directly impact the yield, purity, and efficacy of the final drug product. Therefore, sourcing this compound from a reputable pharmaceutical intermediate manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. is crucial for maintaining production integrity and compliance with regulatory standards.
For companies looking to buy methyl 4-chloro-7-methoxyquinoline-6-carboxylate, our firm offers a streamlined procurement process, competitive pricing, and comprehensive technical support. We understand the critical timelines and quality demands inherent in pharmaceutical production. By ensuring a consistent supply of this high purity lenvatinib intermediate, we empower our clients to accelerate their drug development pipelines and bring essential cancer treatments to patients more efficiently.
The significance of Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate cannot be overstated in the context of modern cancer therapy. It is more than just a chemical compound; it is an enabling component for a drug that offers hope to patients battling challenging forms of cancer. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a part of this critical supply chain, delivering the quality and reliability that the pharmaceutical industry demands.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
